Are Peptides coming off of the FDA Category 2 list? A legal breakdown. The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Reclassifies BPC 157 & TB 500 What the Research Shows #Shorts YouTube BPC 157 (Body Protection Compound 157) Peptide for Tissue Repair & R ELITE BIO COMPOUNDS FDA mulls compounding for peptides previously flagged over safety risks BioSpace